Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 20.91
+0.77 (3.82%)
Apr 7, 2026, 4:00 PM EDT
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 8.32 billion as of April 7, 2026. Its market cap has increased by 179.17% in one year.
Market Cap
8.32B
Enterprise Value
8.24B
Revenue
677.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.91
Market Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 8.32B, an increase of 246.77%. That is a compound annual growth rate of 35.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 8.32B | -14.30% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGI Genomics | 15.07B |
| Guangzhou Kingmed Diagnostics Group | 12.04B |
| Dian Diagnostics Group | 11.25B |
| Amoy Diagnostics | 8.73B |
| Shanghai Runda Medical Technology | 7.46B |
| Beijing Strong Biotechnologies,Inc. | 6.93B |
| Maccura Biotechnology Co.Ltd | 6.52B |
| Thalys Medical Technology Group | 5.00B |